• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于妇科恶性肿瘤患者,为缓解症状而行盆腔廓清术是否合理?

Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?

机构信息

Oxford University Hospital, Headington, Oxford, OX3 7LJ, UK,

出版信息

Arch Gynecol Obstet. 2014 Mar;289(3):657-62. doi: 10.1007/s00404-013-3023-5. Epub 2013 Sep 12.

DOI:10.1007/s00404-013-3023-5
PMID:24026090
Abstract

OBJECTIVE

To review the outcomes of pelvic exenterative surgery done with a palliative intent and evaluate its role in relapsed gynaecology malignancies.

METHOD

This is a retrospective cohort study between April 2009 and May 2012 in Oxford Gynaecological Cancer Centre. Patients were identified from the oncology surgical database.

RESULTS

18 patients were identified with a mean age 54 (26-79) years, who underwent surgery for symptomatic recurrent cancer. All except one patient had radiotherapy prior to surgery. 12 patients had cervical cancer, five had vulval cancer and one had endometrial cancer. About half of the patients had major surgical complications; however, majority was patients satisfied with the outcome.

CONCLUSION

Pelvic exenteration in this context carries considerable morbidity and in this series achieved good symptom control with a mean overall survival of 11 months. Careful patient selection, adequate counselling and ongoing support are imperative of successful outcome.

摘要

目的

回顾以姑息为目的进行的盆腔根治性切除术的结果,并评估其在复发性妇科恶性肿瘤中的作用。

方法

这是 2009 年 4 月至 2012 年 5 月在牛津妇科癌症中心进行的回顾性队列研究。从肿瘤外科数据库中确定患者。

结果

18 名患者平均年龄 54(26-79)岁,因症状性复发性癌症接受手术。除一名患者外,所有患者在手术前均接受过放疗。12 例为宫颈癌,5 例为外阴癌,1 例为子宫内膜癌。约一半的患者发生严重手术并发症;然而,大多数患者对结果满意。

结论

在这种情况下,盆腔根治性切除术具有相当大的发病率,本系列患者的总体生存时间为 11 个月,平均生存时间为 11 个月,症状控制良好。成功的结果需要对患者进行仔细的选择、充分的咨询和持续的支持。

相似文献

1
Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?对于妇科恶性肿瘤患者,为缓解症状而行盆腔廓清术是否合理?
Arch Gynecol Obstet. 2014 Mar;289(3):657-62. doi: 10.1007/s00404-013-3023-5. Epub 2013 Sep 12.
2
Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.盆腔廓清术在晚期和复发性妇科癌症中的潜在治愈和缓解症状作用。
Anticancer Res. 2019 Oct;39(10):5631-5637. doi: 10.21873/anticanres.13759.
3
Pelvic exenterations for gynecological malignancies: a study of 36 cases.盆腔脏器切除术治疗妇科恶性肿瘤:36 例研究。
Int J Gynecol Cancer. 2012 Jun;22(5):889-96. doi: 10.1097/IGC.0b013e31824eb8cd.
4
Indications for primary and secondary exenterations in patients with cervical cancer.宫颈癌患者原发和继发眼眶内容剜除术的适应症。
Gynecol Oncol. 2006 Dec;103(3):1023-30. doi: 10.1016/j.ygyno.2006.06.027. Epub 2006 Aug 4.
5
Pelvic exenteration for primary and recurrent gynaecological malignancies.原发性和复发性妇科恶性肿瘤的盆腔脏器切除术
Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):243-8. doi: 10.1016/j.ejogrb.2006.07.025. Epub 2006 Sep 6.
6
Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer.腹腔镜评估可改善复发性宫颈癌和子宫内膜癌患者的广泛性子宫切除术的病例选择。
J Obstet Gynaecol. 2021 Nov;41(8):1252-1256. doi: 10.1080/01443615.2020.1867963. Epub 2021 Mar 1.
7
Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.妇科癌症盆腔脏器切除术:拉巴斯大学医院经验
Int J Gynecol Cancer. 2015 Jul;25(6):1109-14. doi: 10.1097/IGC.0000000000000435.
8
[Pelvic exenterations for gynaecological cancer--a 10 year institutional review].[妇科癌症盆腔脏器清除术——一项为期10年的机构回顾]
Acta Med Port. 2006 Mar-Apr;19(2):99-104. Epub 2006 Aug 18.
9
Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery.侧向延伸骨盆切除术治疗妇科恶性肿瘤:超越常规手术的多中心经验。
Ann Surg Oncol. 2019 Feb;26(2):523-530. doi: 10.1245/s10434-018-07088-8. Epub 2018 Dec 11.
10
Prognostic factors in pelvic exenteration for gynecological malignancies.妇科恶性肿瘤盆腔廓清术的预后因素。
Eur J Surg Oncol. 2012 Oct;38(10):948-54. doi: 10.1016/j.ejso.2012.07.002. Epub 2012 Jul 18.

引用本文的文献

1
A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients.癌症患者全盆腔脏器切除术死亡率的系统评价和荟萃分析。
BMC Cancer. 2024 May 15;24(1):593. doi: 10.1186/s12885-024-12377-5.
2
Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.妇科癌症患者盆腔廓清术前和术后患者报告结局的前瞻性评估。
Gynecol Oncol. 2018 Jun;149(3):484-490. doi: 10.1016/j.ygyno.2018.03.054. Epub 2018 Apr 2.